Genotropin and Adenoidal hypertrophy - a phase IV clinical study of FDA data

Summary:

Adenoidal hypertrophy is reported as a side effect among people who take Genotropin (somatropin recombinant), especially for people who are female, 2-9 old, have been taking the drug for 1 - 6 months also take Atropine, and have Small for dates baby.

The phase IV clinical study analyzes which people have Adenoidal hypertrophy when taking Genotropin. It is created by eHealthMe based on reports of 41,867 people who have side effects when taking Genotropin from the FDA, and is updated regularly.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.

What is Adenoidal hypertrophy?

Adenoidal hypertrophy (enlarged adenoids) is found to be associated with 44 drugs and 139 conditions by eHealthMe. Check the latest studies of Adenoidal hypertrophy.

On Aug, 05, 2026

41,867 people reported to have side effects when taking Genotropin.
Among them, 23 people (0.05%) have Adenoidal hypertrophy.

Could Genotropin cause Adenoidal hypertrophy?

Among these 23 people:

How long have people been on Genotropin when they have Adenoidal hypertrophy? *

What is the gender of people who have Adenoidal hypertrophy when taking Genotropin? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Adenoidal hypertrophy when taking Genotropin? *

What are other drugs people take besides Genotropin? *

What are other side effects people have besides Adenoidal hypertrophy? *

Tonsillar Hypertrophy (enlargement of the tonsils): 9 people, 39.13%
Sleep Apnea Syndrome: 5 people, 21.74%
Breathing - Slowed Or Stopped: 5 people, 21.74%
Snoring: 4 people, 17.39%
Head Injury: 3 people, 13.04%
Sinus Disorder (disease of sinus): 3 people, 13.04%
Respiratory Disorder (respiratory disease): 3 people, 13.04%
Pituitary Tumor Benign: 3 people, 13.04%
Injection Site Pruritus (severe itching at injection site): 3 people, 13.04%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 2 people, 8.70%

What are the existing conditions these people have? *

Small For Dates Baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age): 4 people, 17.39%
Body Height Below Normal: 3 people, 13.04%
Growth Retardation (delayed growth): 2 people, 8.70%
Thyroid Diseases: 1 person, 4.35%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 4.35%
Intracranial Aneurysm (bulging, weak area in the wall of a cranial artery): 1 person, 4.35%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 1 person, 4.35%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 4.35%
Bone Development Abnormal: 1 person, 4.35%
Adenoiditis (inflammation of an abnormally enlarged mass of lymphoid tissue at the back of the pharynx): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Genotropin and have Adenoidal hypertrophy?

- Check whether Adenoidal hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Genotropin:

Genotropin (41,924 reports)

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adenoidal hypertrophy:

Adenoidal hypertrophy (44 drugs)

Browse all the conditions that are associated with Adenoidal hypertrophy:

Adenoidal hypertrophy (139 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Genotropin) and Genotropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.